Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases Meeting Abstract
| Authors: | Tung, N. M.; Im, S. A.; Senkus-Konefka, E.; Xu, B.; Domchek, S. M.; Masuda, N.; Li, W.; Armstrong, A. C.; Conte, P. F.; Wu, W.; Goessl, C. D.; Runswick, S.; Robson, M. E. |
| Abstract Title: | Olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer (OlympiAD): Efficacy in patients with visceral metastases |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 47s |
| Language: | English |
| ACCESSION: | WOS:000442916001074 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.1052 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1052 -- Source: Wos |
